besthealtharticle.com
Home »
On Friday, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion for the IL-13 inhibitor tralokinumab (Adtralza) for the treatment of adults with moderate-to-severe atopic dermatitis (AD) who are eligible for systemic therapy. The new opinion represents the final stages before the European Commission decides […]
Skip to: What is nitric oxide? Treatments for eczema and other skin conditions Using nitric oxide to treat eczema Eczema is a skin condition that causes the skin to become red, cracked, dry, and very irritated. There are many different forms of topical treatment for eczema and its related skin conditions. The anti-inflammatory effects of […]
(HealthDay)—Children with atopic dermatitis (AD) have worse sleep quality, according to a study published online March 4 in JAMA Pediatrics. Faustine D. Ramirez, from the University of California in San Francisco, and colleagues conducted a longitudinal cohort study involving 13,988 children alive at 1 year and followed up with repeated measures of self-reported AD and […]